Milestone Scientific (MLSS) EBIT (2010 - 2026)

Milestone Scientific (MLSS) has 17 years of EBIT data on file, last reported at -$828083.0 in Q1 2026.

• For the quarter ending Q1 2026, EBIT rose 58.55% year-over-year to -$828083.0; the trailing twelve-month figure through Mar 2026 stood at -$4.5 million (up 37.69% YoY), and the FY2025 full-year result was -$5.7 million, up 15.69% from the prior year.
• EBIT climbed to -$828083.0 in Q1 2026, from -$1.1 million in the prior quarter.
• In the past five years, EBIT ranged from a high of -$828083.0 in Q1 2026 to a low of -$2.9 million in Q2 2022.
• A 5-year average of -$1.7 million and a median of -$1.8 million in 2024 frame the typical range for EBIT.
• Across the five-year window, EBIT plunged 94.49% in 2022 and jumped 58.55% in 2026, its largest moves.
• Tracing MLSS's EBIT over 5 years: stood at -$2.0 million in 2022, then grew by 2.06% to -$2.0 million in 2023, then declined by 3.51% to -$2.0 million in 2024, then soared by 47.13% to -$1.1 million in 2025, then increased by 23.3% to -$828083.0 in 2026.
• Business Quant data shows MLSS's EBIT at -$828083.0 in Q1 2026, -$1.1 million in Q4 2025, and -$1.1 million in Q3 2025.